Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific

Raph L. Hamers; Rebecca Oyomopito; Cissy Kityo; Praphan Phanuphak; Margaret Siwale; Somnuek Sungkanuparph; Francesca Conradie; Nagalingeswaran Kumarasamy; Mariette E. Botes; Thira Sirisanthana; Saade Abdallah; Patrick C.K. Li; Nicoletta Ngorima; Pacharee Kantipong; Akin Osibogun; Christopher K.C. Lee; Wendy S. Stevens; Adeeba Kamarulzaman; Inge Derdelinckx; Yi Ming Arthur Chen; Rob Schuurman; Michèle Van vugt; Tobias F. Rinke de wit; C. Njovu; M. Labib; J. Menke; I. Sanne; C. L. Wallis; M. Hardman; M. Wellington; R. Luthy; K. Mandaliya; I. Jao; M. Dolan; G. Namayanja; L. Nakatudde; M. Kiconco; M. Abwola; P. Mugyenyi; N. Ndembiz; P. Kaleebu; S. Akanmu; A. M. Wensing; K. Sigaloff; E. Straatsma; M. P. Lee; K. H. Wong; S. Saghayam; S. Pujari; K. Joshi; T. P. Merati; F. Yuliana; L. L. Low; L. Y. Ong; M. Mustafa; N. Nordin; R. Ditangco; R. O. Bantique; W. W. Wong; Y. W. Yang; S. Sirivichayakul; B. Piyavong; J. Praparattanapan; P. Kambua; J. Y. Choi; S. H. Han; W. Ratanasuwan; R. Sriondee; R. Kantor; A. H. Sohn; L. Messerschmidt; T. Singtoroj; D. A. Cooper; M. G. Law; A. Jiamsakul; J. Zhou

doi:10.1093/ije/dyq192

Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific

Raph L. Hamers, Rebecca Oyomopito, Cissy Kityo, Praphan Phanuphak, Margaret Siwale, Somnuek Sungkanuparph, Francesca Conradie, Nagalingeswaran Kumarasamy, Mariette E. Botes, Thira Sirisanthana, Saade Abdallah, Patrick C.K. Li, Nicoletta Ngorima, Pacharee Kantipong, Akin Osibogun, Christopher K.C. Lee, Wendy S. Stevens, Adeeba Kamarulzaman, Inge Derdelinckx, Yi Ming Arthur ChenRob Schuurman, Michèle Van vugt, Tobias F. Rinke de wit, C. Njovu, M. Labib, J. Menke, I. Sanne, C. L. Wallis, M. Hardman, M. Wellington, R. Luthy, K. Mandaliya, I. Jao, M. Dolan, G. Namayanja, L. Nakatudde, M. Kiconco, M. Abwola, P. Mugyenyi, N. Ndembiz, P. Kaleebu, S. Akanmu, A. M. Wensing, K. Sigaloff, E. Straatsma, M. P. Lee, K. H. Wong, S. Saghayam, S. Pujari, K. Joshi, T. P. Merati, F. Yuliana, L. L. Low, L. Y. Ong, M. Mustafa, N. Nordin, R. Ditangco, R. O. Bantique, W. W. Wong, Y. W. Yang, S. Sirivichayakul, B. Piyavong, J. Praparattanapan, P. Kambua, J. Y. Choi, S. H. Han, W. Ratanasuwan, R. Sriondee, R. Kantor, A. H. Sohn, L. Messerschmidt, T. Singtoroj, D. A. Cooper, M. G. Law, A. Jiamsakul, J. Zhou

Department of Internal Medicine

Research output: Contribution to journal › Article › peer-review

50 Citations (Scopus)

Original language	English
Article number	dyq192
Pages (from-to)	43-54
Number of pages	12
Journal	International journal of epidemiology
Volume	41
Issue number	1
DOIs	https://doi.org/10.1093/ije/dyq192
Publication status	Published - 2012 Feb

Bibliographical note

Funding Information:
The PharmAccess African Studies to Evaluate Resistance is an initiative of PharmAccess Foundation, supported by the Ministry of Foreign Affairs of The Netherlands through a partnership with Stichting Aids Fonds (grant no 12454). The TREAT Asia Studies to Evaluate Resistance is an initiative of TREAT Asia, a programme of amfAR, The Foundation for AIDS Research, with major support provided by the Ministry of Foreign Affairs of The Netherlands through a partnership with Stichting Aids Fonds (grant no 12454), and with additional support from amfAR and the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) and the National Cancer Institute (NCI) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) (grant no U01AI069907). Queen Elizabeth Hospital and the Integrated Treatment Centre are supported by the Hong Kong Council for AIDS Trust Fund. The National Centre in HIV Epidemiology and Clinical Research is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, The University of New South Wales. The funders had no role in the study design, data collection, data analysis, data interpretation, decision to publish or writing of the report. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above.

Funding Information:
Through the LAASER programme, PASER and TASER receive financial support from the Dutch Ministry of Foreign Affairs through a partnership with Stichting Aids Fonds, PharmAccess Foundation, TREAT Asia (a programme of amfAR, The Foundation for AIDS research) and International Civil Society Support. PASER-M is coordinated by PharmAccess Foundation, in collaboration with the Amsterdam Institute for Global Health and Development (AIGHD) and the Virology Department at the University Medical Center Utrecht, The Netherlands. TASER-M is coordinated by TREAT Asia and its statistical and data management centre is the National Centre in HIV Epidemiology and Clinical Research (NCHECR), The University of New South Wales in Sydney, Australia.

All Science Journal Classification (ASJC) codes

Epidemiology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/ije/dyq192

Cite this

Hamers, R. L., Oyomopito, R., Kityo, C., Phanuphak, P., Siwale, M., Sungkanuparph, S., Conradie, F., Kumarasamy, N., Botes, M. E., Sirisanthana, T., Abdallah, S., Li, P. C. K., Ngorima, N., Kantipong, P., Osibogun, A., Lee, C. K. C., Stevens, W. S., Kamarulzaman, A., Derdelinckx, I., ... Zhou, J. (2012). Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific. International journal of epidemiology, 41(1), 43-54. Article dyq192. https://doi.org/10.1093/ije/dyq192

@article{e8d1681392af49ac851de50957ca44cd,

title = "Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific",

author = "Hamers, {Raph L.} and Rebecca Oyomopito and Cissy Kityo and Praphan Phanuphak and Margaret Siwale and Somnuek Sungkanuparph and Francesca Conradie and Nagalingeswaran Kumarasamy and Botes, {Mariette E.} and Thira Sirisanthana and Saade Abdallah and Li, {Patrick C.K.} and Nicoletta Ngorima and Pacharee Kantipong and Akin Osibogun and Lee, {Christopher K.C.} and Stevens, {Wendy S.} and Adeeba Kamarulzaman and Inge Derdelinckx and Chen, {Yi Ming Arthur} and Rob Schuurman and {Van vugt}, Mich{\`e}le and {Rinke de wit}, {Tobias F.} and C. Njovu and M. Labib and J. Menke and I. Sanne and Wallis, {C. L.} and M. Hardman and M. Wellington and R. Luthy and K. Mandaliya and I. Jao and M. Dolan and G. Namayanja and L. Nakatudde and M. Kiconco and M. Abwola and P. Mugyenyi and N. Ndembiz and P. Kaleebu and S. Akanmu and Wensing, {A. M.} and K. Sigaloff and E. Straatsma and Lee, {M. P.} and Wong, {K. H.} and S. Saghayam and S. Pujari and K. Joshi and Merati, {T. P.} and F. Yuliana and Low, {L. L.} and Ong, {L. Y.} and M. Mustafa and N. Nordin and R. Ditangco and Bantique, {R. O.} and Wong, {W. W.} and Yang, {Y. W.} and S. Sirivichayakul and B. Piyavong and J. Praparattanapan and P. Kambua and Choi, {J. Y.} and Han, {S. H.} and W. Ratanasuwan and R. Sriondee and R. Kantor and Sohn, {A. H.} and L. Messerschmidt and T. Singtoroj and Cooper, {D. A.} and Law, {M. G.} and A. Jiamsakul and J. Zhou",

note = "Funding Information: The PharmAccess African Studies to Evaluate Resistance is an initiative of PharmAccess Foundation, supported by the Ministry of Foreign Affairs of The Netherlands through a partnership with Stichting Aids Fonds (grant no 12454). The TREAT Asia Studies to Evaluate Resistance is an initiative of TREAT Asia, a programme of amfAR, The Foundation for AIDS Research, with major support provided by the Ministry of Foreign Affairs of The Netherlands through a partnership with Stichting Aids Fonds (grant no 12454), and with additional support from amfAR and the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) and the National Cancer Institute (NCI) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) (grant no U01AI069907). Queen Elizabeth Hospital and the Integrated Treatment Centre are supported by the Hong Kong Council for AIDS Trust Fund. The National Centre in HIV Epidemiology and Clinical Research is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, The University of New South Wales. The funders had no role in the study design, data collection, data analysis, data interpretation, decision to publish or writing of the report. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above. Funding Information: Through the LAASER programme, PASER and TASER receive financial support from the Dutch Ministry of Foreign Affairs through a partnership with Stichting Aids Fonds, PharmAccess Foundation, TREAT Asia (a programme of amfAR, The Foundation for AIDS research) and International Civil Society Support. PASER-M is coordinated by PharmAccess Foundation, in collaboration with the Amsterdam Institute for Global Health and Development (AIGHD) and the Virology Department at the University Medical Center Utrecht, The Netherlands. TASER-M is coordinated by TREAT Asia and its statistical and data management centre is the National Centre in HIV Epidemiology and Clinical Research (NCHECR), The University of New South Wales in Sydney, Australia.",

year = "2012",

month = feb,

doi = "10.1093/ije/dyq192",

language = "English",

volume = "41",

pages = "43--54",

journal = "International journal of epidemiology",

issn = "0300-5771",

publisher = "Oxford University Press",

number = "1",

}

Hamers, RL, Oyomopito, R, Kityo, C, Phanuphak, P, Siwale, M, Sungkanuparph, S, Conradie, F, Kumarasamy, N, Botes, ME, Sirisanthana, T, Abdallah, S, Li, PCK, Ngorima, N, Kantipong, P, Osibogun, A, Lee, CKC, Stevens, WS, Kamarulzaman, A, Derdelinckx, I, Chen, YMA, Schuurman, R, Van vugt, M, Rinke de wit, TF, Njovu, C, Labib, M, Menke, J, Sanne, I, Wallis, CL, Hardman, M, Wellington, M, Luthy, R, Mandaliya, K, Jao, I, Dolan, M, Namayanja, G, Nakatudde, L, Kiconco, M, Abwola, M, Mugyenyi, P, Ndembiz, N, Kaleebu, P, Akanmu, S, Wensing, AM, Sigaloff, K, Straatsma, E, Lee, MP, Wong, KH, Saghayam, S, Pujari, S, Joshi, K, Merati, TP, Yuliana, F, Low, LL, Ong, LY, Mustafa, M, Nordin, N, Ditangco, R, Bantique, RO, Wong, WW, Yang, YW, Sirivichayakul, S, Piyavong, B, Praparattanapan, J, Kambua, P, Choi, JY, Han, SH, Ratanasuwan, W, Sriondee, R, Kantor, R, Sohn, AH, Messerschmidt, L, Singtoroj, T, Cooper, DA, Law, MG, Jiamsakul, A & Zhou, J 2012, 'Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific', International journal of epidemiology, vol. 41, no. 1, dyq192, pp. 43-54. https://doi.org/10.1093/ije/dyq192

Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific. / Hamers, Raph L.; Oyomopito, Rebecca; Kityo, Cissy et al.
In: International journal of epidemiology, Vol. 41, No. 1, dyq192, 02.2012, p. 43-54.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Cohort profile

T2 - The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific

AU - Hamers, Raph L.

AU - Oyomopito, Rebecca

AU - Kityo, Cissy

AU - Phanuphak, Praphan

AU - Siwale, Margaret

AU - Sungkanuparph, Somnuek

AU - Conradie, Francesca

AU - Kumarasamy, Nagalingeswaran

AU - Botes, Mariette E.

AU - Sirisanthana, Thira

AU - Abdallah, Saade

AU - Li, Patrick C.K.

AU - Ngorima, Nicoletta

AU - Kantipong, Pacharee

AU - Osibogun, Akin

AU - Lee, Christopher K.C.

AU - Stevens, Wendy S.

AU - Kamarulzaman, Adeeba

AU - Derdelinckx, Inge

AU - Chen, Yi Ming Arthur

AU - Schuurman, Rob

AU - Van vugt, Michèle

AU - Rinke de wit, Tobias F.

AU - Njovu, C.

AU - Labib, M.

AU - Menke, J.

AU - Sanne, I.

AU - Wallis, C. L.

AU - Hardman, M.

AU - Wellington, M.

AU - Luthy, R.

AU - Mandaliya, K.

AU - Jao, I.

AU - Dolan, M.

AU - Namayanja, G.

AU - Nakatudde, L.

AU - Kiconco, M.

AU - Abwola, M.

AU - Mugyenyi, P.

AU - Ndembiz, N.

AU - Kaleebu, P.

AU - Akanmu, S.

AU - Wensing, A. M.

AU - Sigaloff, K.

AU - Straatsma, E.

AU - Lee, M. P.

AU - Wong, K. H.

AU - Saghayam, S.

AU - Pujari, S.

AU - Joshi, K.

AU - Merati, T. P.

AU - Yuliana, F.

AU - Low, L. L.

AU - Ong, L. Y.

AU - Mustafa, M.

AU - Nordin, N.

AU - Ditangco, R.

AU - Bantique, R. O.

AU - Wong, W. W.

AU - Yang, Y. W.

AU - Sirivichayakul, S.

AU - Piyavong, B.

AU - Praparattanapan, J.

AU - Kambua, P.

AU - Choi, J. Y.

AU - Han, S. H.

AU - Ratanasuwan, W.

AU - Sriondee, R.

AU - Kantor, R.

AU - Sohn, A. H.

AU - Messerschmidt, L.

AU - Singtoroj, T.

AU - Cooper, D. A.

AU - Law, M. G.

AU - Jiamsakul, A.

AU - Zhou, J.

N1 - Funding Information: The PharmAccess African Studies to Evaluate Resistance is an initiative of PharmAccess Foundation, supported by the Ministry of Foreign Affairs of The Netherlands through a partnership with Stichting Aids Fonds (grant no 12454). The TREAT Asia Studies to Evaluate Resistance is an initiative of TREAT Asia, a programme of amfAR, The Foundation for AIDS Research, with major support provided by the Ministry of Foreign Affairs of The Netherlands through a partnership with Stichting Aids Fonds (grant no 12454), and with additional support from amfAR and the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) and the National Cancer Institute (NCI) as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) (grant no U01AI069907). Queen Elizabeth Hospital and the Integrated Treatment Centre are supported by the Hong Kong Council for AIDS Trust Fund. The National Centre in HIV Epidemiology and Clinical Research is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, The University of New South Wales. The funders had no role in the study design, data collection, data analysis, data interpretation, decision to publish or writing of the report. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above. Funding Information: Through the LAASER programme, PASER and TASER receive financial support from the Dutch Ministry of Foreign Affairs through a partnership with Stichting Aids Fonds, PharmAccess Foundation, TREAT Asia (a programme of amfAR, The Foundation for AIDS research) and International Civil Society Support. PASER-M is coordinated by PharmAccess Foundation, in collaboration with the Amsterdam Institute for Global Health and Development (AIGHD) and the Virology Department at the University Medical Center Utrecht, The Netherlands. TASER-M is coordinated by TREAT Asia and its statistical and data management centre is the National Centre in HIV Epidemiology and Clinical Research (NCHECR), The University of New South Wales in Sydney, Australia.

PY - 2012/2

Y1 - 2012/2

UR - http://www.scopus.com/inward/record.url?scp=84863383426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863383426&partnerID=8YFLogxK

U2 - 10.1093/ije/dyq192

DO - 10.1093/ije/dyq192

M3 - Article

C2 - 21071386

AN - SCOPUS:84863383426

SN - 0300-5771

VL - 41

SP - 43

EP - 54

JO - International journal of epidemiology

JF - International journal of epidemiology

IS - 1

M1 - dyq192

ER -

Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this